Two-year translational fellowships that pay scientists to develop their own discovery
Postdocs who discover something promising usually have to leave it behind when their contract ends. A fellowship would pay them for two years to turn it into a candidate drug or diagnostic, with mentors from industry.
Fellowships with salary, a project budget of $250,000 to $500,000 and structured mentoring from drug developers, regulatory experts and clinicians, awarded to postdoctoral scientists or clinical fellows to translate a specific finding: target validation, lead optimisation, assay development, prototype device. Fellows are hosted in translational institutes or academic drug discovery units and have the option to found a company or license the asset. Precedents include the Wellcome and MRC translational fellowships, Blavatnik Fellowships and the EMBL-EBI industry programme; oncology lacks a dedicated scheme at scale.
- The valley of death between lab and product · Most academic discoveries die before anyone tests them in people because nobody funds the middle step.
- Not enough oncologists, nurses, pathologists, physicists · The number of people with cancer is rising faster than the workforce trained to treat them.
Pages like this
not linked directly; found by shared links- InstitutionCancer Prevention and Research Institute of Texas
Shares Not enough oncologists, nurses, pathologists, physicists, The valley of death between lab and product.
- IdeaAn open engineering platform for academic ADCs and bispecifics
Shares Regional translational institutes with academic GMP suites and IND teams, The valley of death between lab and product.
- IdeaShared modular GMP facilities for academic personalised vaccines and cell products
Shares Regional translational institutes with academic GMP suites and IND teams, The valley of death between lab and product.
- IdeaA national non-profit contract research organisation for academic oncology trials
Shares Regional translational institutes with academic GMP suites and IND teams, The valley of death between lab and product.
- IdeaScale up public drug development that takes academic assets to phase 1
Shares Regional translational institutes with academic GMP suites and IND teams, The valley of death between lab and product.
- IdeaA global first-in-human network for academic cancer trials with single ethics review
Shares Regional translational institutes with academic GMP suites and IND teams, The valley of death between lab and product.
- IdeaA fast IND-enabling fund that pays for toxicology and manufacturing in eight weeks
Shares Regional translational institutes with academic GMP suites and IND teams, The valley of death between lab and product.
- IdeaHospital-exemption cell therapies at scale, backed by a shared registry
Shares Regional translational institutes with academic GMP suites and IND teams, The valley of death between lab and product.